πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 30 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12419958

Clinical formulations

Astellas Institute for Regenerative Medicine Β· Granted Tue Sep 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12209255

Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses ther

Astellas Institute for Regenerative Medicine Β· Granted Tue Jan 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 23 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12109239

Methods for production of human hemogenic endothelial cells from pluripotent stem cells an

Astellas Institute for Regenerative Medicine Β· Granted Tue Oct 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 03 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12097223

Mesenchymal stromal cells and uses related thereto

Astellas Institute for Regenerative Medicine Β· Granted Tue Sep 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12076347

Methods for production of platelets from pluripotent stem cells and compositions thereof

Astellas Institute for Regenerative Medicine Β· Granted Tue Sep 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12049642

Corneal endothelial cells with increased cell density and compositions thereof

Astellas Institute for Regenerative Medicine Β· Granted Tue Jul 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11957754

Clinical formulations

Astellas Institute for Regenerative Medicine Β· Granted Tue Apr 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11850261

Methods of producing human RPE cells and pharmaceutical preparations of human RPE cells

Astellas Institute for Regenerative Medicine Β· Granted Tue Dec 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11566228

Hemangio-colony forming cells

Astellas Institute for Regenerative Medicine Β· Granted Tue Jan 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11400118

Methods for production of platelets from pluripotent stem cells and compositions thereof

Astellas Institute for Regenerative Medicine Β· Granted Tue Aug 02 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11241460

Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells

Astellas Institute for Regenerative Medicine Β· Granted Tue Feb 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11013808

Clinical formulations

Astellas Institute for Regenerative Medicine Β· Granted Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10894065

Methods for production of platelets from pluripotent stem cells and compositions thereof

Astellas Institute for Regenerative Medicine Β· Granted Tue Jan 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10584313

Method of producing a differentiated mammalian cell comprising culturing a single mammalia

Astellas Institute for Regenerative Medicine Β· Granted Tue Mar 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10485829

Methods of producing human RPE cells and pharmaceutical preparations of human RPE cells

Astellas Institute for Regenerative Medicine Β· Granted Tue Nov 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10426799

Methods for production of platelets from pluripotent stem cells and compositions thereof

Astellas Institute for Regenerative Medicine Β· Granted Tue Oct 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10307444

Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells

Astellas Institute for Regenerative Medicine Β· Granted Tue Jun 04 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10077424

Methods of producing RPE cells and compositions of RPE cells

Astellas Institute for Regenerative Medicine Β· Granted Tue Sep 18 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10072243

Derivation of embryonic stem cells and embryo-derived cells

Astellas Institute for Regenerative Medicine Β· Granted Tue Sep 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9993503

Methods for production of platelets from pluripotent stem cells and compositions thereof

Astellas Institute for Regenerative Medicine Β· Granted Tue Jun 12 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9988602

Methods for producing enucleated erythroid cells derived from pluripotent stem cells

Astellas Institute for Regenerative Medicine Β· Granted Tue Jun 05 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 31 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9938500

Hemangio-colony forming cells

Astellas Institute for Regenerative Medicine Β· Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9763984

Methods for production of platelets from pluripotent stem cells and compositions thereof

Astellas Institute for Regenerative Medicine Β· Granted Tue Sep 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9752118

Method of directed differentiation producing corneal endothelial cells from neural crest s

Astellas Institute for Regenerative Medicine Β· Granted Tue Sep 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 31 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted